Moody’s affirms Palmetto Health’s ‘Baa1’ rating

Moody’s Investors Service has affirmed Columbia, S.C.-based Palmetto Health’s “Baa1” rating, affecting $484 million of debt.

Advertisement

The rating affirmation reflects a number of factors, including Palmetto’s large size and important role in its market as an academic medical center and teaching hospital for Columbia-based University of South Carolina School of Medicine.

Palmetto Health also faces several challenges, including integration risks with a recently acquired hospital.

The outlook is stable, reflecting Moody’s Investors Service’s view that Palmetto will maintain operating performance at its current levels.

More articles on healthcare finance:
Coding error points to administrative glitch at St. Mark’s Hospital
As hospitals increasingly hire oncologists, chemo costs rise
US annual spending on prescription drugs to reach $400 billion by 2020

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.